IHC results from ZSHS cohort validated M1 polarization (P = 0.041; Fig. 4D) and low CD8+ T cells infiltration of dual-loss ccRCC (P = 0.003; Fig. 4D). This evidence concerns the gene CD8A and nonpapillary renal cell carcinoma.